Tech Company Financing Transactions
OxyPlus Funding Round
On 9/10/2007, OxyPlus received $8 million in Series A funding from Index Ventures.
Transaction Overview
Company Name
Announced On
9/10/2007
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
300 Market St.
Boston, MA 02135
USA
Boston, MA 02135
USA
Phone
Email Address
Not Recorded
Overview
OxyPlus is a developer of small molecule compounds for the treatment of cardiovascular issues and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/10/2007: SolarCity venture capital transaction
Next: 9/10/2007: Positive Energy venture capital transaction
Share this article
About Our VC Transactions Data
We report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs